FindTrial
Sign In

A before and after study on improvement of quality of life in chronic plaque psoriasis

Studying the action of individualized Homeopathic medicines on QoL (Quality of Life) of the patient with chronic plaque psoriasis by using DLQI (Dermatology life quality index): An experimental, Pre & Post-test study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050291
Enrollment
30
Registered
2023-03-03
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L400- Psoriasis vulgaris

Interventions

Intervention1: INDIVIDUALIZED HOMEOPATHIC MEDICINES: PRESCRIBING INDIVIDUALIZED HOMEOPATHIC MEDICINES ACCORDING TO THE HOMEOPATHIC POSOLOGICAL INDICATIONS. Intervention2: Homoeopathic medicines: Indiv

Sponsors

Dr Krupa Kadu
Lead Sponsor
Smt Malini Kishore sanghvi Homeopathic medical college and Hospital
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of chronic plaque psoriasis, with duration of illness since minimum 2 years.

Exclusion criteria

Exclusion criteria: Patient suffering from other skin diseases or systemic illnesses which may influence the QoL such as stroke,other CNS disorders,vitiligo, eczema, etc

Design outcomes

Primary

MeasureTime frame
Physical and mental aspects of health of QoL(Quality of Life) using DLQI (Dermatology Life Quality Index)Timepoint: 12 months—

Secondary

MeasureTime frame
Change in susceptibility and efficacy of medicines using RREF and using DLQI (Dermatology Life Quality Index)Timepoint: 1 year—

Countries

India

Contacts

Public ContactDr Krupa Kadu

Smt. Mallini kishore sanghvi Homeopathic medical college and hospital

drhmparikh@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026